(Q51856187)

14 April 2018

title

Comprehensive control of human papillomavirus infections and related diseases. (English)

1 reference

14 April 2018

Papillomavirus infections

main subject

1 reference

Ginesa Albero

28

0 references

Mireia Díaz

Mireia Diaz

29

0 references

Marc Steben

Marc Steben

19

0 references

Xavier Castellsagué

Xavier Castellsagué

24

0 references

Eduardo L. Franco

Eduardo L Franco

18

0 references

Mark Schiffman

21

Mark Schiffman

1 reference

14 April 2018

14

Lauri E Markowitz

1 reference

14 April 2018

Karen Canfell

16

Karen Canfell

1 reference

14 April 2018

Margaret Stanley

8

Margaret Stanley

1 reference

14 April 2018

Silvia de Sanjosé

30

Silvia de Sanjosé

1 reference

14 April 2018

Chris J L M Meijer

22

Chris J L M Meijer

1 reference

14 April 2018

Anna-Barbara Moscicki

4

Anna-Barbara Moscicki

1 reference

14 April 2018

John Doorbar

6

John Doorbar

1 reference

14 April 2018

Peter Stern

7

Peter L Stern

1 reference

14 April 2018

Philip E. Castle

12

Philip E Castle

1 reference

14 April 2018

Lynette A Denny

17

Lynette A Denny

1 reference

14 April 2018

Rengaswamy Sankaranarayanan

23

Rengaswamy Sankaranarayanan

1 reference

14 April 2018

Laia Alemany Perez

27

Laia Alemany

1 reference

14 April 2018

Maura L. Gillison

5

Maura L Gillison

1 reference

14 April 2018

Jack Cuzick

11

Jack Cuzick

1 reference

14 April 2018

Francesc Xavier Bosch José

1

F Xavier Bosch

1 reference

14 April 2018

author name string

Thomas R Broker

2

1 reference

14 April 2018

David Forman

3

1 reference

14 April 2018

Marc Arbyn

9

1 reference

14 April 2018

Mario Poljak

10

1 reference

14 April 2018

John T Schiller

13

1 reference

14 April 2018

William A Fisher

15

1 reference

14 April 2018

Mark A Kane

20

1 reference

14 April 2018

Jane J Kim

25

1 reference

14 April 2018

Maria Brotons

26

1 reference

14 April 2018

authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012

31

1 reference

14 April 2018

language of work or name

English

0 references

publication date

1 December 2013

1 reference

14 April 2018

published in

Vaccine

1 reference

14 April 2018

volume

31 Suppl 7

1 reference

14 April 2018

page(s)

H1-31

1 reference

14 April 2018

Global burden of human papillomavirus and related diseases.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Updating the natural history of human papillomavirus and anogenital cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

The biology and life-cycle of human papillomaviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Therapy of human papillomavirus-related disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Nucleic acid tests for the detection of alpha human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

New technologies and procedures for cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Introduction of human papillomavirus DNA screening in the world: 15 years of experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Human papillomavirus vaccines--immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

A review of clinical trials of human papillomavirus prophylactic vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Human papillomavirus vaccine introduction--the first five years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Understanding human papillomavirus vaccine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Modeling preventative strategies against human papillomavirus-related disease in developed countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Human papillomavirus, human immunodeficiency virus and immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Implementation of human papillomavirus immunization in the developing world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.003

Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24332295

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Global prevention and management of human papillomavirus related diseases: the pressing challenges and the compelling opportunities. Foreword

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24332295

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2013.10.003

1 reference

14 April 2018

1 reference

14 April 2018